Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
Product Portfolio, Meda
Bioengineered cell culture systems of central nervous system injury and disease.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
Masitinib is being investigated in the treatment of amyotrophic lateral sclerosis (ALS)
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
PHENYTEK®* Capsules (extended phenytoin sodium capsules, USP)
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
Statement on a nonproprietary name adopted by the USAN Council
Posturography in MS patients treated with high dose methylprednisolone.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.

Pages